These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29530313)

  • 21. Ontogeny and the Application of Pharmacogenomics to Pediatric Drug Development.
    Green D
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S82-S86. PubMed ID: 31502695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacoepigenetics: an element of personalized therapy?
    Majchrzak-Celińska A; Baer-Dubowska W
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):387-398. PubMed ID: 27860490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives.
    Zhao J; Bian J; Zhao Y; Li Y; Liu B; Hao X; He S; Huang L
    Paediatr Drugs; 2023 May; 25(3):301-319. PubMed ID: 36707496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
    Mooij MG; Nies AT; Knibbe CA; Schaeffeler E; Tibboel D; Schwab M; de Wildt SN
    Clin Pharmacokinet; 2016 May; 55(5):507-24. PubMed ID: 26410689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet?
    Davies SM
    Hematology Am Soc Hematol Educ Program; 2006; ():111-7. PubMed ID: 17124048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic biomarkers and personalized medicine: application in cardiovascular pharmacology].
    Carrillo Norte JA
    Rev Enferm; 2013 Jan; 36(1):41-50. PubMed ID: 23427736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacogenetics or the promise of a personalized medicine: variability in drug metabolism and transport].
    Allorge D; Loriot MA
    Ann Biol Clin (Paris); 2004; 62(5):499-511. PubMed ID: 15355800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenomics in pediatric rheumatology.
    Becker ML
    Curr Opin Rheumatol; 2012 Sep; 24(5):541-7. PubMed ID: 22732686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomic information in FDA-approved drug labels: Application to pediatric patients.
    Green DJ; Mummaneni P; Kim IW; Oh JM; Pacanowski M; Burckart GJ
    Clin Pharmacol Ther; 2016 Jun; 99(6):622-32. PubMed ID: 26693845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ontogeny of Hepatic Drug Transporters and Relevance to Drugs Used in Pediatrics.
    Elmorsi Y; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2016 Jul; 44(7):992-8. PubMed ID: 26712821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Targets in Advanced Therapeutics of Cancers: The Role of Pharmacogenetics.
    Abubakar MB; Gan SH
    Oncology; 2016; 91(1):3-12. PubMed ID: 27233906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current perspective on pediatric pharmacogenomics.
    Abaji R; Krajinovic M
    Expert Opin Drug Metab Toxicol; 2016; 12(4):363-5. PubMed ID: 26799591
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacomicrobiomics: a novel route towards personalized medicine?
    Doestzada M; Vila AV; Zhernakova A; Koonen DPY; Weersma RK; Touw DJ; Kuipers F; Wijmenga C; Fu J
    Protein Cell; 2018 May; 9(5):432-445. PubMed ID: 29705929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic drug monitoring as a component of personalized medicine: applications in pediatric drug development.
    Momper JD; Wagner JA
    Clin Pharmacol Ther; 2014 Feb; 95(2):138-40. PubMed ID: 24253660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
    Oscarson M
    Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Personalizing pediatric pain medicine: using population-specific pharmacogenetics, genomics, and other -omics approaches to predict response.
    Jimenez N; Galinkin JL
    Anesth Analg; 2015 Jul; 121(1):183-187. PubMed ID: 26086515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric clinical pharmacology. A practical review.
    Udkow G
    Am J Dis Child; 1978 Oct; 132(10):1025-32. PubMed ID: 362892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Affymetrix DMET platform and pharmacogenetics in drug development.
    Deeken J
    Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics: personalizing pediatric heart transplantation.
    Van Driest SL; Webber SA
    Circulation; 2015 Feb; 131(5):503-12. PubMed ID: 25645611
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.
    Elie V; de Beaumais T; Fakhoury M; Jacqz-Aigrain E
    Pharmacogenomics; 2011 Jun; 12(6):827-43. PubMed ID: 21692614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.